| Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. MD Dial S, Alrasadi K, Manoukian C, Huang A Canadian Medical Association Journal, 2004 | 751* | 2004 |
| Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel Expert Opin Drug Saf. 14 (6), 935-955, 2015 | 574* | 2015 |
| Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci. 11 (1), 1-23, 2015 | 574* | 2015 |
| Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe … RD Santos, SS Gidding, RA Hegele, MA Cuchel, PJ Barter, GF Watts, ... The lancet Diabetes & endocrinology 4 (10), 850-861, 2016 | 376 | 2016 |
| Potential effects of curcumin in the treatment of COVID‐19 infection F Zahedipour, SA Hosseini, T Sathyapalan, M Majeed, T Jamialahmadi, ... Phytotherapy Research 34 (11), 2911-2920, 2020 | 335 | 2020 |
| Statins and the COVID-19 main protease: in silico evidence on direct interaction Ž Reiner, M Hatamipour, M Banach, M Pirro, K Al-Rasadi, T Jamialahmadi, ... Archives of Medical Science 16 (3), 490-496, 2020 | 286 | 2020 |
| Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways K Koushki, SK Shahbaz, K Mashayekhi, M Sadeghi, ZD Zayeri, MY Taba, ... Clinical reviews in allergy & immunology 60, 175-199, 2021 | 230 | 2021 |
| Familial hypercholesterolaemia: a global call to arms AJ Vallejo-Vaz, SRK Seshasai, D Cole, GK Hovingh, JJP Kastelein, ... Atherosclerosis 243 (1), 257-259, 2015 | 205 | 2015 |
| Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ... Atherosclerosis 277, 234-255, 2018 | 194 | 2018 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 180 | 2021 |
| Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action KA Wilemon, J Patel, C Aguilar-Salinas, CD Ahmed, M Alkhnifsawi, ... JAMA cardiology 5 (2), 217-229, 2020 | 180 | 2020 |
| Natural approaches in metabolic syndrome management AM Patti, K Al-Rasadi, RV Giglio, D Nikolic, C Mannina, G Castellino, ... Archives of Medical Science 14 (2), 422-441, 2018 | 123 | 2018 |
| Estimated glomerular filtration rate (eGFR): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice ARD Mula-Abed WA, Al Rasadi K Oman medical journal 27 (4), 339, 2012 | 123* | 2012 |
| Vascular calcifications in homozygote familial hypercholesterolemia Z Awan, K Alrasadi, GA Francis, RA Hegele, R McPherson, J Frohlich, ... Arteriosclerosis, thrombosis, and vascular biology 28 (4), 777-785, 2008 | 123 | 2008 |
| The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: a consensus statement from the … JC Fruchart, RD Santos, C Aguilar-Salinas, M Aikawa, K Al Rasadi, ... Cardiovascular diabetology 18, 1-20, 2019 | 120 | 2019 |
| Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) N Danchin, W Almahmeed, K Al-Rasadi, J Azuri, A Berrah, CA Cuneo, ... European journal of preventive cardiology 25 (10), 1087-1094, 2018 | 113 | 2018 |
| Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS … AJ Vallejo-Vaz, A Akram, SRK Seshasai, D Cole, GF Watts, GK Hovingh, ... Atherosclerosis Supplements 22, 1-32, 2016 | 113 | 2016 |
| 2023 update on European atherosclerosis society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance M Cuchel, FJ Raal, RA Hegele, K Al-Rasadi, M Arca, M Averna, ... European heart journal 44 (25), 2277-2291, 2023 | 84 | 2023 |
| Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels? AFG Cicero, F Fogacci, AP Stoian, M Vrablik, K Al Rasadi, M Banach, ... Current atherosclerosis reports 23, 1-14, 2021 | 73 | 2021 |
| Criteria for diagnosis of familial hypercholesterolemia: a comprehensive analysis of the different guidelines, appraising their suitability in the Omani Arab population K Al-Rasadi, K Al-Waili, HA Al-Sabti, A Al-Hinai, K Al-Hashmi, ... Oman medical journal 29 (2), 85, 2014 | 73 | 2014 |
Maciej BanachSecretary, European Atherosclerosis Society & President, International Lipid Expert Panel; Poland在 umed.lodz.pl 的电子邮件经过验证
